GHTM

Global Health and Tropical Medicine

  • GHTM
    • Vision
    • Mission
    • Governance
    • Scientific Advisory Board
  • News
    • Outreach
    • Events
      • GHTM Sessions
      • Workshops
    • Articles
    • Jobs
  • Research
    • Cross-cutting issues
      • Global Pathogen Dispersion and Population Mobility
      • Drug Discovery and Drug Resistance
      • Diagnostics
      • Public Health Information
      • Fair Research Partnerships
    • Research Groups
      • PPS – Population health, policies and services
      • THOP – TB, HIV and opportunistic diseases and pathogens
      • VBD – Vector borne diseases and pathogens
      • IHC – Individual health care
    • Research in numbers
      • 2020
      • 2019
      • 2018
      • 2017
    • Projects
      • Ongoing Projects
    • Members
      • Population health, policies and services
        • PPS PhD members
        • PPS non PhD members
      • TB, HIV and opportunistic diseases and pathogens
        • THOP PhD members
        • THOP non PhD members
      • Vector-borne diseases and pathogens
        • VBD PhD members
        • VBD non PhD members
      • Individual Health Care
        • IHC PhD members
        • IHC non PhD members
      • Technical / administrative support
  • Publications
  • Education
    • Master Theses
    • PhD Theses
  • Services
Home / Publicações / Differences between synthetic ß-haematin and native hemozoin crystals

Differences between synthetic ß-haematin and native hemozoin crystals

  • Autores: Carvalho PA, Coelho L, Martins RC, Nogueira F
  • Ano de Publicação: 2013
  • Journal: Microscopy and Microanalysis
  • Link: https://www.cambridge.org/core/journals/microscopy-and-microanalysis/article/differences-between-synthetic-haematin-and-native-hemozoin-crystals/8E5EF17D25DF24F909FB9A57FF1D72CA

Plasmodium falciparum causes the most severe/lethal form of malaria, a parasitic infection that affects 500 million people worldwide and leads to the death of nearly one million/year, about 91% being due to P. falciparum. The malaria pigment or hemozoin crystals (HZ) are formed in an enzyme-independent polymerization of heme released during haemoglobin digestion by the parasite during the intra-erythrocytic life cycle. The quinoline and artemisinin based antimalarials (the only available treatment options) appear to act by disrupting the formation of HZ. Therefore, the development of antimalarial agents based on the physicochemical process of heme crystallization appears a good option to drug design.

We have produced β-haematin following an assay adapted from the method described by Basilico et al, with modifications. Briefly, hemin (ferriprotoporphyrin IX chloride; Sigma-Aldrich) was dissolved NaOH and polymerized by the addition of acetic acid and incubation at 37°C. Resulting pellet washed with dimethyl sulfoxide (DMSO) to remove unpolymerized hemin and resuspended in H2O. To extract native HZ (nHZ) from P. falciparum (clone Dd2)-infected erythrocytes, when parasitemia reached >10%, parasites were harvested by saponin lysis, washed with phosphate-buffered saline (PBS) and sonicated in 2% sodium dodecyl sulfate (SDS), further washed in 2% SDS and pellet was resuspended (10 mM Tris-HCl (pH 8.0); 0.5% SDS; 2mg/ml of proteinase K) and incubated at 37°C overnight. The nHZ pellet was washed in 2% SDS and in distilled H2O, then resuspended in distilled H2O water and sonicated again prior to use to minimize aggregation and maintain the nHZ in suspension. β-haematin and native nHZ crystals were analysed by Scanning Electron Microscopy (JEOL 7001FSEM) (Fig.1; A, B.1 and C.1) and Transmission Electron Microscopy (Hitachi H8100) (Fig.1; B.2 and C.2).

Here we report the crystal morphology of nHZ produced by the Plasmodium falciparum clone Dd2 and of β-haematin produced with the above protocol. Chemically, HZ is a stable dimer of iron(III)(protoporphyrin[PP]-IX), also known as β-hematin and consists of heme units dimerized through reciprocal iron-carboxylate bonds. Even though the parasite nHZ and synthetic β-hematin are isostructural, there are large differences in the crystal morphologies of nHZ (Dd2) and β-hematin as evidenced by SEM and TEM images (Fig.1). nHZ crystals are remarkably uniform in size and shape, adopting a parallelipede morphology with high aspect ratio of about 800x200x200 nm (Fig. 1 C1 and C2). Different protocols to prepare β-haematin yield diverse material, which can be poorly crystalline and heterogeneous within the same sample. The present results show that β-haematin is rather homogeneous and constituted by needle-like particles of sizes similar to those presented by nHZ ones (compare B1 with C1). Higher resolution observations evidence differences between the β-haematin and nHZ materials, since the latter seems constituted by uniform flat layers and the former shows flaked ones (Fig. B2).

Morphology seems to be of biological relevance, since structure-function studies revealed that the size and shape of the synthetic crystals influence their ability to activate, for instance, the inflammatory responses in vitro and in vivo. Several protocols have been developed to measure drug inhibition of heme crystallization in vitro although it has been difficult to standardize these assays. In the present study, we report a new method for β-haematin preparation that renders homogenous crystals, both in shape and size, favourable for reproducible drug inhibition of heme crystallization assays.

Share this:

  • Click to share on Facebook (Opens in new window)
  • Click to share on Twitter (Opens in new window)
  • Click to share on LinkedIn (Opens in new window)
  • Click to share on Pinterest (Opens in new window)
  • Click to share on WhatsApp (Opens in new window)
  • Click to print (Opens in new window)

Events

NOVA Sciencepreneur program: registration is open

  The Sciencepreneur ® program is aimed at NOVA scientists who are seeking to create value … [Read More...]

IHMT selected for the pilot phase of the Research Data Repository Service of the FCT

  In order to promote good practices in Open Science with regard to research data and … [Read More...]

Paulo Ferrinho interviewed for the new e-magazine of European and Developing Countries Clinical Trials Partnership (EDCTP)

Paulo Ferrinho, professor and Diretor of Public Global Health Departament at the Instituto de … [Read More...]

How can we improve the environmental performance of our laboratories?

  Every day in NOVA's laboratories research is carried out with the consumption of numerous … [Read More...]

Call for PhD Studentships

The Institute of Hygiene and Tropical Medicine (IHMT), Universidade Nova de Lisboa (NOVA), through … [Read More...]

IHMT | GHTM – APPLICATIONS ARE OPEN!

IHMT | GHTM - Applications are open for three research vacancies:   One position - PhD … [Read More...]

About GHTM

GHTM is a R&D Center that brings together researchers from IHMT with a track record in Tropical Medicine and International/Global Health. It aims at strengthening Portugal's role as a leading partner in the development and implementation of a global health research agenda. Our evidence-based interventions contribute to the promotion of equity in health and to improve the health of populations.

Contacts

Rua da Junqueira, 100
1349-008 Lisboa
Portugal
+351 213 652 600
+351 213 632 105

  • Facebook
  • YouTube

Subscribe Newsletter

  • How to get to GHTM/IHMT
  • GHTM Sessions
  • Research Groups
  • Cross-cutting issues
© Copyright 2023 IHMT-UNL Todos os Direitos Reservados.
  • Universidade Nova de Lisboa
  • Fundação para a Ciência e a Tecnologia

    Project UID/Multi/04413/2013